Essex Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,893
Closed -$876K 36
2021
Q4
$876K Buy
3,893
+24
+0.6% +$5.07K 0.74% 22
2021
Q3
$823K Sell
3,869
-42
-1% -$9.67K 0.75% 24
2021
Q2
$953K Sell
3,911
-54
-1% -$13.3K 0.87% 23
2021
Q1
$987K Sell
3,965
-403
-9% -$96.2K 0.94% 23
2020
Q4
$1M Hold
4,368
0.98% 24
2020
Q3
$1.11M Sell
4,368
-31
-0.7% -$7.68K 1.15% 22
2020
Q2
$1.04M Sell
4,399
-2
-0% -$456 1.2% 20
2020
Q1
$892K Sell
4,401
-452
-9% -$98.7K 1.16% 20
2019
Q4
$1.17M Buy
+4,853
New +$1.07M 1.18% 20

Other funds holding AMGN

Essex Private Wealth Management's AMGN Position: Q1 2022 in Review

Essex Private Wealth Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 3,893 shares — an estimated $876K sold.

Essex Private Wealth Management first reported a position in AMGN in Q4 2019 and held it in 9 quarters. The position peaked at $1.17M in Q4 2019. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Essex Private Wealth Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Essex Private Wealth Management sold 3,893 Amgen shares in Q1 2022, an estimated $876K.
  • Essex Private Wealth Management first reported a position in Amgen in Q4 2019 and held it in 9 quarters.
  • Essex Private Wealth Management's Amgen position peaked at $1.17M in Q4 2019.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Essex Private Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.